Literature DB >> 19635920

Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses.

Motoyuki Tanaka1, Stephan R Krutzik, Peter A Sieling, Delphine J Lee, Thomas H Rea, Robert L Modlin.   

Abstract

The formation of immune complexes results in activation of the innate immune system and subsequent induction of host inflammatory responses. In particular, the binding of IgG immune complexes to FcgammaR on monocytes triggers potent inflammatory responses leading to tissue injury in disease. We investigated whether activation of monocytes via FcgammaR induced cell differentiation, imparting specific inflammatory functions of the innate immune response. Human IgG alone induced monocytes to differentiate into cells with an immature dendritic cell (iDC) phenotype, including up-regulation of CD1b, CD80, CD86, and CD206. Differentiation into CD1b(+) iDC was dependent on activation via CD64 (FcgammaRI) and induction of GM-CSF. The human IgG-differentiated iDC were phenotypically different from GM-CSF-derived iDC at the same level of CD1b expression, with higher cell surface CD86, but lower MHC class II, CD32, CD206, and CD14. Finally, in comparison to GM-CSF-derived iDC, IgG-differentiated iDC were more efficient in activating T cells in both autologous and allogeneic mixed lymphocyte reactions but less efficient at presenting microbial Ag to T cells. Therefore, activation of FcgammaRI on monocytes triggers differentiation into specialized iDC with the capacity to expand autoreactive T cells that may contribute to the pathogenesis of immune complex-mediated tissue injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635920      PMCID: PMC2790276          DOI: 10.4049/jimmunol.0801683

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Regulation of T cell immunity by dendritic cells.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase.

Authors:  J M Debets; J G Van de Winkel; J L Ceuppens; I E Dieteren; W A Buurman
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

4.  Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.

Authors:  J Krutmann; R Kirnbauer; A Köck; T Schwarz; E Schöpf; L T May; P B Sehgal; T A Luger
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

Review 5.  The pathogenesis of autoimmune diseases.

Authors:  H M Lorenz; M Herrmann; J R Kalden
Journal:  Scand J Clin Lab Invest Suppl       Date:  2001

6.  Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway.

Authors:  Zoltán Bánki; Laco Kacani; Brigitte Müllauer; Doris Wilflingseder; Gerlinde Obermoser; Harald Niederegger; Harald Schennach; Georg M Sprinzl; Norbert Sepp; Anna Erdei; Manfred P Dierich; Heribert Stoiber
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 7.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

8.  Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2.

Authors:  C J Hertz; S M Kiertscher; P J Godowski; D A Bouis; M V Norgard; M D Roth; R L Modlin
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 9.  Physiological and pathological aspects of circulating immune complexes.

Authors:  J A Schifferli; R P Taylor
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

10.  A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

Authors:  S M Behar; S A Porcelli; E M Beckman; M B Brenner
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

2.  CD31 Acts as a Checkpoint Molecule and Is Modulated by FcγR-Mediated Signaling in Monocytes.

Authors:  Giovanna Merchand-Reyes; Frank H Robledo-Avila; Nathaniel J Buteyn; Shalini Gautam; Ramasamy Santhanam; Kavin Fatehchand; Xiaokui Mo; Santiago Partida-Sanchez; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

3.  The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.

Authors:  William E O'Gorman; Huang Huang; Yu-Ling Wei; Kara L Davis; Michael D Leipold; Sean C Bendall; Brian A Kidd; Cornelia L Dekker; Holden T Maecker; Yueh-Hsiu Chien; Mark M Davis
Journal:  Vaccine       Date:  2014-09-06       Impact factor: 3.641

4.  Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.

Authors:  Kacper A Wojtal; Gerhard Rogler; Michael Scharl; Luc Biedermann; Pascal Frei; Michael Fried; Achim Weber; Jyrki J Eloranta; Gerd A Kullak-Ublick; Stephan R Vavricka
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 5.  SLE-associated risk factors affect DC function.

Authors:  Myoungsun Son; Sun Jung Kim; Betty Diamond
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

6.  MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.

Authors:  Naomi I Maria; Zana Brkic; Matti Waris; Cornelia G van Helden-Meeuwsen; Kim Heezen; Joop P van de Merwe; Paul L van Daele; Virgil A S H Dalm; Hemmo A Drexhage; Marjan A Versnel
Journal:  Ann Rheum Dis       Date:  2013-07-06       Impact factor: 19.103

7.  Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.

Authors:  Ana-Maria Buga; Claus Jürgen Scholz; Senthil Kumar; James G Herndon; Dragos Alexandru; Gabriel Radu Cojocaru; Thomas Dandekar; Aurel Popa-Wagner
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

8.  Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment.

Authors:  Peter Matt; Ulla Lindqvist; Sandra Kleinau
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  Deregulated Fcγ receptor expression in patients with CIDP.

Authors:  Isaak Quast; Flavio Cueni; Falk Nimmerjahn; Björn Tackenberg; Jan D Lünemann
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-08-20

10.  A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.

Authors:  Hélène Haegel; Christine Thioudellet; Rémy Hallet; Michel Geist; Thierry Menguy; Fabrice Le Pogam; Jean-Baptiste Marchand; Myew-Ling Toh; Vanessa Duong; Alexandre Calcei; Nathalie Settelen; Xavier Preville; Marie Hennequi; Benoit Grellier; Philippe Ancian; Jukka Rissanen; Pascal Clayette; Christine Guillen; Ronald Rooke; Jean-Yves Bonnefoy
Journal:  MAbs       Date:  2013-07-15       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.